GeneDx Holdings Ownership

GeneDx Holdings Corp has a total of 27.47 Million outstanding shares. The majority of GeneDx Holdings Corp outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in GeneDx Holdings to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in GeneDx Holdings Corp. Please pay attention to any change in the institutional holdings of GeneDx Holdings Corp as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as GeneDx Holdings in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of GeneDx Holdings, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Dividend Paid And Capex Coverage Ratio is likely to gain to -29.97 in 2024. Common Stock Shares Outstanding is likely to gain to about 25.5 M in 2024, despite the fact that Net Loss is likely to grow to (469.4 M). Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in GeneDx Holdings Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.